10-Q Filing
Filing Information
| Form Type | 10-Q |
| Accession Number | 0001639691-18-000044 |
| Period End Date | 20180331 |
| Filing Date | 20180503 |
| Fiscal Year | 2018 |
| Fiscal Period | Q1 |
| XBRL Instance | livn-20180331.xml |
Filing Contents
This filing contains the following financial statements:
Balance Sheet
80 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Ordinary shares, par value (in Pounds per Share) |
CommonStockParOrStatedValuePerShare
|
1.00 | GBP | Point-in-time |
| Ordinary shares, par value (in Pounds per Share) |
CommonStockParOrStatedValuePerShare
|
1.00 | GBP | Point-in-time |
| Ordinary shares issued (shares) |
CommonStockSharesIssued
|
48.29M | shares | Point-in-time |
| Ordinary shares issued (shares) |
CommonStockSharesIssued
|
48.63M | shares | Point-in-time |
| Ordinary shares outstanding (shares) |
CommonStockSharesOutstanding
|
48.29M | shares | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$64.96M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$62.72M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$93.61M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$39.79M | USD | Point-in-time |
| Ordinary shares outstanding (shares) |
CommonStockSharesOutstanding
|
48.43M | shares | Point-in-time |
| Accounts receivable, net |
AccountsReceivableNetCurrent
|
$282.14M | USD | Point-in-time |
| Treasury stock (shares) |
TreasuryStockShares
|
2,930.00 | shares | Point-in-time |
| Treasury stock (shares) |
TreasuryStockShares
|
199,130.00 | shares | Point-in-time |
| Accounts receivable, net |
AccountsReceivableNetCurrent
|
$279.83M | USD | Point-in-time |
| Inventories |
InventoryNet
|
$144.47M | USD | Point-in-time |
| Inventories |
InventoryNet
|
$154.33M | USD | Point-in-time |
| Prepaid and refundable taxes |
PrepaidTaxes
|
$46.27M | USD | Point-in-time |
| Prepaid and refundable taxes |
PrepaidTaxes
|
$47.06M | USD | Point-in-time |
| Assets held for sale |
AssetsHeldForSaleNotPartOfDisposalGroup
|
$13.65M | USD | Point-in-time |
| Assets held for sale |
AssetsHeldForSaleNotPartOfDisposalGroup
|
$13.63M | USD | Point-in-time |
| Assets of discontinued operations |
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
|
$257.14M | USD | Point-in-time |
| Assets of discontinued operations |
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
|
$250.69M | USD | Point-in-time |
| Prepaid expenses and other current assets |
PrepaidExpenseAndOtherAssetsCurrent
|
$31.10M | USD | Point-in-time |
| Prepaid expenses and other current assets |
PrepaidExpenseAndOtherAssetsCurrent
|
$39.04M | USD | Point-in-time |
| Total Current Assets |
AssetsCurrent
|
$869.86M | USD | Point-in-time |
| Total Current Assets |
AssetsCurrent
|
$848.07M | USD | Point-in-time |
| Property, plant and equipment, net |
PropertyPlantAndEquipmentNet
|
$191.70M | USD | Point-in-time |
| Property, plant and equipment, net |
PropertyPlantAndEquipmentNet
|
$192.36M | USD | Point-in-time |
| Goodwill |
Goodwill
|
$784.24M | USD | Point-in-time |
| Goodwill |
Goodwill
|
$875.56M | USD | Point-in-time |
| Intangible assets, net |
FiniteLivedIntangibleAssetsNet
|
$691.99M | USD | Point-in-time |
| Intangible assets, net |
FiniteLivedIntangibleAssetsNet
|
$535.40M | USD | Point-in-time |
| Investments |
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
|
$22.08M | USD | Point-in-time |
| Investments |
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
|
$34.49M | USD | Point-in-time |
| Deferred tax assets, net |
DeferredTaxAssetsLiabilitiesNetNoncurrent
|
$11.56M | USD | Point-in-time |
| Deferred tax assets, net |
DeferredTaxAssetsLiabilitiesNetNoncurrent
|
$68.90M | USD | Point-in-time |
| Other assets |
OtherAssetsNoncurrent
|
$75.98M | USD | Point-in-time |
| Other assets |
OtherAssetsNoncurrent
|
$6.56M | USD | Point-in-time |
| Total Assets |
Assets
|
$2.50B | USD | Point-in-time |
| Total Assets |
Assets
|
$2.70B | USD | Point-in-time |
| Current debt obligations |
DebtCurrent
|
$119.71M | USD | Point-in-time |
| Current debt obligations |
DebtCurrent
|
$84.03M | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$85.92M | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$89.92M | USD | Point-in-time |
| Accrued liabilities and other |
AccruedLiabilitiesCurrent
|
$78.94M | USD | Point-in-time |
| Accrued liabilities and other |
AccruedLiabilitiesCurrent
|
$81.75M | USD | Point-in-time |
| Taxes payable |
TaxesPayableCurrent
|
$12.12M | USD | Point-in-time |
| Taxes payable |
TaxesPayableCurrent
|
$12.83M | USD | Point-in-time |
| Accrued employee compensation and related benefits |
EmployeeRelatedLiabilitiesCurrent
|
$66.22M | USD | Point-in-time |
| Accrued employee compensation and related benefits |
EmployeeRelatedLiabilitiesCurrent
|
$70.98M | USD | Point-in-time |
| Liabilities of discontinued operations |
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
|
$84.99M | USD | Point-in-time |
| Liabilities of discontinued operations |
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
|
$78.08M | USD | Point-in-time |
| Total Current Liabilities |
LiabilitiesCurrent
|
$406.02M | USD | Point-in-time |
| Total Current Liabilities |
LiabilitiesCurrent
|
$459.48M | USD | Point-in-time |
| Long-term debt obligations |
LongTermDebtNoncurrent
|
$63.65M | USD | Point-in-time |
| Long-term debt obligations |
LongTermDebtNoncurrent
|
$61.96M | USD | Point-in-time |
| Deferred income taxes liability |
DeferredTaxLiabilitiesNoncurrent
|
$123.34M | USD | Point-in-time |
| Deferred income taxes liability |
DeferredTaxLiabilitiesNoncurrent
|
$149.70M | USD | Point-in-time |
| Long-term employee compensation and related benefits |
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
|
$29.09M | USD | Point-in-time |
| Long-term employee compensation and related benefits |
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
|
$28.18M | USD | Point-in-time |
| Other long-term liabilities |
OtherLiabilitiesNoncurrent
|
$183.98M | USD | Point-in-time |
| Other long-term liabilities |
OtherLiabilitiesNoncurrent
|
$69.08M | USD | Point-in-time |
| Total Liabilities |
Liabilities
|
$688.58M | USD | Point-in-time |
| Total Liabilities |
Liabilities
|
$885.89M | USD | Point-in-time |
| Commitments and contingencies (Note 11) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Commitments and contingencies (Note 11) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Ordinary Shares, 1.00 par value: unlimited shares authorized; 48,627,730 shares issued and 48,428,600 shares outstanding at March 31, 2018; 48,290,276 shares issued and 48,287,346 shares outstanding at December 31, 2017 |
CommonStockValue
|
$74.75M | USD | Point-in-time |
| Ordinary Shares, 1.00 par value: unlimited shares authorized; 48,627,730 shares issued and 48,428,600 shares outstanding at March 31, 2018; 48,290,276 shares issued and 48,287,346 shares outstanding at December 31, 2017 |
CommonStockValue
|
$75.22M | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapitalCommonStock
|
$1.74B | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapitalCommonStock
|
$1.74B | USD | Point-in-time |
| Accumulated other comprehensive income |
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
|
$45.31M | USD | Point-in-time |
| Accumulated other comprehensive income |
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
|
$54.91M | USD | Point-in-time |
| Retained deficit |
RetainedEarningsAccumulatedDeficit
|
$-39.66M | USD | Point-in-time |
| Retained deficit |
RetainedEarningsAccumulatedDeficit
|
$-48.82M | USD | Point-in-time |
| Treasury stock at cost, 199,130 shares at March 31, 2018 and 2,930 shares at December 31, 2017 |
TreasuryStockValue
|
$375.00K | USD | Point-in-time |
| Treasury stock at cost, 199,130 shares at March 31, 2018 and 2,930 shares at December 31, 2017 |
TreasuryStockValue
|
$133.00K | USD | Point-in-time |
| Total Stockholders Equity |
StockholdersEquity
|
$1.82B | USD | Point-in-time |
| Total Stockholders Equity |
StockholdersEquity
|
$1.82B | USD | Point-in-time |
| Total Liabilities and Stockholders Equity |
LiabilitiesAndStockholdersEquity
|
$2.70B | USD | Point-in-time |
| Total Liabilities and Stockholders Equity |
LiabilitiesAndStockholdersEquity
|
$2.50B | USD | Point-in-time |
Income Statement
58 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net sales |
SalesRevenueNet
|
$250.40M | USD | 1 Quarter |
| Net sales |
SalesRevenueNet
|
$226.82M | USD | 1 Quarter |
| Cost of sales |
CostOfGoodsAndServicesSold
|
$79.97M | USD | 1 Quarter |
| Cost of sales |
CostOfGoodsAndServicesSold
|
$84.60M | USD | 1 Quarter |
| Product remediation |
CostofGoodsSoldProductRemediation
|
$3.71M | USD | 1 Quarter |
| Product remediation |
CostofGoodsSoldProductRemediation
|
$-792.00K | USD | 1 Quarter |
| Gross profit |
GrossProfit
|
$162.09M | USD | 1 Quarter |
| Gross profit |
GrossProfit
|
$147.65M | USD | 1 Quarter |
| Selling, general and administrative |
SellingGeneralAndAdministrativeExpense
|
$87.34M | USD | 1 Quarter |
| Selling, general and administrative |
SellingGeneralAndAdministrativeExpense
|
$104.16M | USD | 1 Quarter |
| Research and development |
ResearchAndDevelopmentExpense
|
$31.75M | USD | 1 Quarter |
| Research and development |
ResearchAndDevelopmentExpense
|
$20.39M | USD | 1 Quarter |
| Merger and integration expenses |
BusinessCombinationIntegrationRelatedCosts
|
$2.96M | USD | 1 Quarter |
| Merger and integration expenses |
BusinessCombinationIntegrationRelatedCosts
|
$2.19M | USD | 1 Quarter |
| Restructuring expenses |
RestructuringCharges
|
$10.03M | USD | 1 Quarter |
| Restructuring expenses |
RestructuringCharges
|
$1.88M | USD | 1 Quarter |
| Amortization of intangibles |
AmortizationOfIntangibleAssets
|
$7.96M | USD | 1 Quarter |
| Amortization of intangibles |
AmortizationOfIntangibleAssets
|
$8.80M | USD | 1 Quarter |
| Total operating expenses |
OperatingExpenses
|
$127.90M | USD | 1 Quarter |
| Total operating expenses |
OperatingExpenses
|
$149.56M | USD | 1 Quarter |
| Operating income from continuing operations |
OperatingIncomeLoss
|
$19.75M | USD | 1 Quarter |
| Operating income from continuing operations |
OperatingIncomeLoss
|
$12.53M | USD | 1 Quarter |
| Interest income |
InvestmentIncomeInterest
|
$273.00K | USD | 1 Quarter |
| Interest income |
InvestmentIncomeInterest
|
$447.00K | USD | 1 Quarter |
| Interest expense |
InterestExpense
|
$2.11M | USD | 1 Quarter |
| Interest expense |
InterestExpense
|
$2.31M | USD | 1 Quarter |
| Gain on acquisition of ImThera Medical, Inc. |
GainfromAcquisition
|
- | USD | 1 Quarter |
| Gain on acquisition of ImThera Medical, Inc. |
GainfromAcquisition
|
$11.48M | USD | 1 Quarter |
| Foreign exchange and other (losses) gains |
ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome
|
$-273.00K | USD | 1 Quarter |
| Foreign exchange and other (losses) gains |
ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome
|
$3.17M | USD | 1 Quarter |
| Income from continuing operations before tax |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$20.88M | USD | 1 Quarter |
| Income from continuing operations before tax |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$22.08M | USD | 1 Quarter |
| Income tax expense |
IncomeTaxExpenseBenefit
|
$5.66M | USD | 1 Quarter |
| Income tax expense |
IncomeTaxExpenseBenefit
|
$3.89M | USD | 1 Quarter |
| Losses from equity method investments |
IncomeLossFromEquityMethodInvestments
|
$-2.00M | USD | 1 Quarter |
| Losses from equity method investments |
IncomeLossFromEquityMethodInvestments
|
$-362.00K | USD | 1 Quarter |
| Net income from continuing operations |
IncomeLossFromContinuingOperations
|
$17.82M | USD | 1 Quarter |
| Net income from continuing operations |
IncomeLossFromContinuingOperations
|
$13.23M | USD | 1 Quarter |
| Net loss from discontinued operations |
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
$-4.55M | USD | 1 Quarter |
| Net loss from discontinued operations |
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
$-1.96M | USD | 1 Quarter |
| Net income |
NetIncomeLoss
|
$13.27M | USD | 1 Quarter |
| Net income |
NetIncomeLoss
|
$11.27M | USD | 1 Quarter |
| Basic income (loss) per share - continuing operation (in Dollars per Share) |
IncomeLossFromContinuingOperationsPerBasicShare
|
$0.28 | USD | 1 Quarter |
| Basic income (loss) per share - continuing operation (in Dollars per Share) |
IncomeLossFromContinuingOperationsPerBasicShare
|
$0.37 | USD | 1 Quarter |
| Basic income (loss) per share - discontinued operation (in Dollars per Share) |
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
|
$-0.05 | USD | 1 Quarter |
| Basic income (loss) per share - discontinued operation (in Dollars per Share) |
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
|
$-0.10 | USD | 1 Quarter |
| Basic income (loss) per share (in Dollars per Share) |
EarningsPerShareBasic
|
$0.27 | USD | 1 Quarter |
| Basic income (loss) per share (in Dollars per Share) |
EarningsPerShareBasic
|
$0.23 | USD | 1 Quarter |
| Diluted income (loss) per share - continuing operation (in Dollars per Share) |
IncomeLossFromContinuingOperationsPerDilutedShare
|
$0.27 | USD | 1 Quarter |
| Diluted income (loss) per share - continuing operation (in Dollars per Share) |
IncomeLossFromContinuingOperationsPerDilutedShare
|
$0.36 | USD | 1 Quarter |
| Diluted income (loss) per share - discontinued operation (in Dollars per Share) |
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
|
$-0.09 | USD | 1 Quarter |
| Diluted income (loss) per share - discontinued operation (in Dollars per Share) |
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
|
$-0.04 | USD | 1 Quarter |
| Diluted income (loss) per share (in Dollars per Share) |
EarningsPerShareDiluted
|
$0.27 | USD | 1 Quarter |
| Diluted income (loss) per share (in Dollars per Share) |
EarningsPerShareDiluted
|
$0.23 | USD | 1 Quarter |
| Shares used in computing basic income (loss) per share (in Shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
48.07M | shares | 1 Quarter |
| Shares used in computing basic income (loss) per share (in Shares) |
WeightedAverageNumberOfSharesOutstandingBasic
|
48.32M | shares | 1 Quarter |
| Shares used in computing diluted income (loss) per share (in Shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
49.19M | shares | 1 Quarter |
| Shares used in computing diluted income (loss) per share (in Shares) |
WeightedAverageNumberOfDilutedSharesOutstanding
|
48.18M | shares | 1 Quarter |
Cash Flow Statement
70 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net income |
NetIncomeLoss
|
$13.27M | USD | 1 Quarter |
| Net income |
NetIncomeLoss
|
$11.27M | USD | 1 Quarter |
| Depreciation |
Depreciation
|
$8.33M | USD | 1 Quarter |
| Depreciation |
Depreciation
|
$8.78M | USD | 1 Quarter |
| Amortization |
AdjustmentForAmortization
|
$11.41M | USD | 1 Quarter |
| Amortization |
AdjustmentForAmortization
|
$8.80M | USD | 1 Quarter |
| Stock-based compensation |
ShareBasedCompensation
|
$3.84M | USD | 1 Quarter |
| Stock-based compensation |
ShareBasedCompensation
|
$6.68M | USD | 1 Quarter |
| Deferred income tax benefit |
DeferredIncomeTaxExpenseBenefit
|
$-922.00K | USD | 1 Quarter |
| Deferred income tax benefit |
DeferredIncomeTaxExpenseBenefit
|
$-5.52M | USD | 1 Quarter |
| Losses from equity method investments |
IncomeLossfromEquityMethodInvestmentsIncludingDiscontinuedOperation
|
$-3.08M | USD | 1 Quarter |
| Losses from equity method investments |
IncomeLossfromEquityMethodInvestmentsIncludingDiscontinuedOperation
|
$-1.57M | USD | 1 Quarter |
| Gain on acquisition of ImThera Medical, Inc. |
GainfromAcquisition
|
- | USD | 1 Quarter |
| Gain on acquisition of ImThera Medical, Inc. |
GainfromAcquisition
|
$11.48M | USD | 1 Quarter |
| Impairment of property, plant and equipment |
GainLossOnDispositionOfAssets1
|
$-458.00K | USD | 1 Quarter |
| Impairment of property, plant and equipment |
GainLossOnDispositionOfAssets1
|
$-4.65M | USD | 1 Quarter |
| Amortization of income taxes payable on inter-company transfers of property |
AmortizationOfDeferredCharges
|
$6.51M | USD | 1 Quarter |
| Amortization of income taxes payable on inter-company transfers of property |
AmortizationOfDeferredCharges
|
$1.98M | USD | 1 Quarter |
| Other |
OtherNoncashIncomeExpense
|
$1.92M | USD | 1 Quarter |
| Other |
OtherNoncashIncomeExpense
|
$1.01M | USD | 1 Quarter |
| Accounts receivable, net |
IncreaseDecreaseInAccountsReceivable
|
$-6.57M | USD | 1 Quarter |
| Accounts receivable, net |
IncreaseDecreaseInAccountsReceivable
|
$-9.11M | USD | 1 Quarter |
| Inventories |
IncreaseDecreaseInInventories
|
$4.44M | USD | 1 Quarter |
| Inventories |
IncreaseDecreaseInInventories
|
$6.30M | USD | 1 Quarter |
| Other current and non-current assets |
IncreaseDecreaseInOtherOperatingAssets
|
$16.69M | USD | 1 Quarter |
| Other current and non-current assets |
IncreaseDecreaseInOtherOperatingAssets
|
$9.31M | USD | 1 Quarter |
| Accounts payable and accrued current and non-current liabilities |
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
$4.95M | USD | 1 Quarter |
| Accounts payable and accrued current and non-current liabilities |
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
$5.70M | USD | 1 Quarter |
| Restructuring reserve |
IncreaseDecreaseInRestructuringReserve
|
$905.00K | USD | 1 Quarter |
| Restructuring reserve |
IncreaseDecreaseInRestructuringReserve
|
$-6.70M | USD | 1 Quarter |
| Net cash provided by operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$20.39M | USD | 1 Quarter |
| Net cash provided by operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$33.21M | USD | 1 Quarter |
| Acquisition of ImThera Medical, Inc., net of cash acquired |
PaymentsToAcquireBusinessesNetOfCashAcquired
|
- | USD | 1 Quarter |
| Acquisition of ImThera Medical, Inc., net of cash acquired |
PaymentsToAcquireBusinessesNetOfCashAcquired
|
$77.63M | USD | 1 Quarter |
| Purchases of property, plant and equipment and other |
PaymentsToAcquirePropertyPlantAndEquipment
|
$7.57M | USD | 1 Quarter |
| Purchases of property, plant and equipment and other |
PaymentsToAcquirePropertyPlantAndEquipment
|
$5.85M | USD | 1 Quarter |
| Proceeds from sale of cost-method investment |
ProceedsFromSaleofCostMethodInvestments
|
$3.19M | USD | 1 Quarter |
| Proceeds from sale of cost-method investment |
ProceedsFromSaleofCostMethodInvestments
|
- | USD | 1 Quarter |
| Loans to equity-method investees |
PaymentsForAdvanceToAffiliate
|
- | USD | 1 Quarter |
| Loans to equity-method investees |
PaymentsForAdvanceToAffiliate
|
$5.34M | USD | 1 Quarter |
| Proceeds from asset sales |
ProceedsFromSaleOfProductiveAssets
|
$123.00K | USD | 1 Quarter |
| Proceeds from asset sales |
ProceedsFromSaleOfProductiveAssets
|
- | USD | 1 Quarter |
| Other |
PaymentsForProceedsFromOtherInvestingActivities
|
- | USD | 1 Quarter |
| Other |
PaymentsForProceedsFromOtherInvestingActivities
|
$361.00K | USD | 1 Quarter |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-10.07M | USD | 1 Quarter |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-83.35M | USD | 1 Quarter |
| Change in short-term borrowing, net |
ProceedsFromRepaymentsOfShortTermDebt
|
$15.50M | USD | 1 Quarter |
| Change in short-term borrowing, net |
ProceedsFromRepaymentsOfShortTermDebt
|
$253.00K | USD | 1 Quarter |
| Proceeds from short-term borrowing (maturities greater than 90 days) |
ProceedsFromShortTermDebt
|
$20.00M | USD | 1 Quarter |
| Proceeds from short-term borrowing (maturities greater than 90 days) |
ProceedsFromShortTermDebt
|
- | USD | 1 Quarter |
| Repayment of long-term debt obligations |
RepaymentsOfLongTermDebt
|
- | USD | 1 Quarter |
| Repayment of long-term debt obligations |
RepaymentsOfLongTermDebt
|
$254.00K | USD | 1 Quarter |
| Proceeds from exercise of stock options |
ProceedsFromStockOptionsExercised
|
$1.61M | USD | 1 Quarter |
| Proceeds from exercise of stock options |
ProceedsFromStockOptionsExercised
|
$876.00K | USD | 1 Quarter |
| Other |
PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
|
$4.81M | USD | 1 Quarter |
| Other |
PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
|
$1.82M | USD | 1 Quarter |
| Net cash provided by (used in) financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$32.05M | USD | 1 Quarter |
| Net cash provided by (used in) financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$-690.00K | USD | 1 Quarter |
| Effect of exchange rate changes on cash and cash equivalents |
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
|
$2.26M | USD | 1 Quarter |
| Effect of exchange rate changes on cash and cash equivalents |
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
|
$484.00K | USD | 1 Quarter |
| Net (decrease) increase in cash and cash equivalents |
CashAndCashEquivalentsPeriodIncreaseDecrease
|
$22.93M | USD | 1 Quarter |
| Net (decrease) increase in cash and cash equivalents |
CashAndCashEquivalentsPeriodIncreaseDecrease
|
$-28.65M | USD | 1 Quarter |
| Cash and cash equivalents at beginning of period |
CashAndCashEquivalentsAtCarryingValue
|
$39.79M | USD | Point-in-time |
| Cash and cash equivalents at beginning of period |
CashAndCashEquivalentsAtCarryingValue
|
$93.61M | USD | Point-in-time |
| Cash and cash equivalents at beginning of period |
CashAndCashEquivalentsAtCarryingValue
|
$64.96M | USD | Point-in-time |
| Cash and cash equivalents at beginning of period |
CashAndCashEquivalentsAtCarryingValue
|
$62.72M | USD | Point-in-time |
| Cash and cash equivalents at end of period |
CashAndCashEquivalentsAtCarryingValue
|
$39.79M | USD | Point-in-time |
| Cash and cash equivalents at end of period |
CashAndCashEquivalentsAtCarryingValue
|
$93.61M | USD | Point-in-time |
| Cash and cash equivalents at end of period |
CashAndCashEquivalentsAtCarryingValue
|
$64.96M | USD | Point-in-time |
| Cash and cash equivalents at end of period |
CashAndCashEquivalentsAtCarryingValue
|
$62.72M | USD | Point-in-time |
Comprehensive Income
14 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net income |
NetIncomeLoss
|
$13.27M | USD | 1 Quarter |
| Net income |
NetIncomeLoss
|
$11.27M | USD | 1 Quarter |
| Net change in unrealized (loss) gains on derivatives |
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPortionAttributableToParent
|
$-1.26M | USD | 1 Quarter |
| Net change in unrealized (loss) gains on derivatives |
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPortionAttributableToParent
|
$-2.63M | USD | 1 Quarter |
| Tax effect |
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxPortionAttributableToParent
|
$-302.00K | USD | 1 Quarter |
| Tax effect |
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxPortionAttributableToParent
|
$-724.00K | USD | 1 Quarter |
| Net of tax |
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent
|
$-955.00K | USD | 1 Quarter |
| Net of tax |
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent
|
$-1.91M | USD | 1 Quarter |
| Foreign currency translation adjustment, net of tax |
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
$10.55M | USD | 1 Quarter |
| Foreign currency translation adjustment, net of tax |
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
$15.43M | USD | 1 Quarter |
| Total other comprehensive income |
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
$13.52M | USD | 1 Quarter |
| Total other comprehensive income |
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
$9.60M | USD | 1 Quarter |
| Total comprehensive income |
ComprehensiveIncomeNetOfTax
|
$24.79M | USD | 1 Quarter |
| Total comprehensive income |
ComprehensiveIncomeNetOfTax
|
$22.87M | USD | 1 Quarter |
Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.